Navigation Links
Healthzone Limited Engages The Trout Group for Investor Relations Services
Date:3/3/2011

SYDNEY, March 3, 2011 /PRNewswire/ -- Healthzone Limited (ASX: HZL; OTCQX: HLTZY) announced that it has entered into a services agreement with The Trout Group LLC ("the Trout Group"), a leading New York-based investor relations and strategic advisory firm. The Trout Group will provide investor relations services for Healthzone for an initial engagement of one year.

With more than 60 current clients, the Trout Group provides investor relations and advisory services exclusively for the life sciences industry. The Trout Group will be assisting Healthzone with its corporate goal to broaden the Company's exposure to institutional investors.

"With Trout's office in Shanghai since 2009, and our long-time support in Australia, we are ideally positioned to help Healthzone meet a broad-base of global institutional investors and analysts," said Brian Korb, Senior Vice President. "Healthzone's existing revenue base of over $100 million, EBITDA of close to $10 million, and their ongoing expansion in China with the recent Eu Yan Sang alliance gives Healthzone a unique story to tell potential investors."

Peter Roach, Healthzone Executive Chairman, said, "We are already experiencing increased share liquidity as a result of the Trout Group's early initiatives and we look forward to the relationship adding value to our efforts to grow value into our share price."

ABOUT HEALTHZONE LIMITEDHealthzone Ltd operates a portfolio of distribution, consumer product and retail business and is the largest operator in the Australian Wellness sector with significant and growing Asian and China wellness market interests. Each business provides immediate opportunities for earnings growth through business development and integration. Healthzone's businesses are comprised of three principal activities; Health and Beauty distribution; Health and Beauty Products, and Health Food Retail. For further information please visit www.healthzone.com.au  

ABOUT THE TROUT GROUP LLCThe Trout Group is a leading investor relations and strategic advisory firm exclusively serving the life sciences industry. Since 1996, the Trout Group has been providing healthcare and biotechnology companies with expert investor relations counsel and access to the institutional investment community. Based on our experience in the biotechnology, pharmaceuticals, medical technology and life science technology sectors, the Trout Group offers our clients the knowledge to clarify investment themes and reach the proper target audience. The Trout Group's global reach extends through a network of offices and contacts in all major financial centers, helping our clients find the right investors. The Trout Group - Relationship Capital. For additional information, please visit www.troutgroup.com.CONTACT:Healthzone LimitedHealthzone LimitedPeter Roach

Michael JenkinsExecutive Chairman

Company SecretaryTel: +612 9772 7100

Tel: +612 9772 7102USAAustraliaThe Trout Group

FCRInvestor Relations

Financial & Corporate RelationsBrian Korb

Ashley RambukwellaTel: +1 646 378 2923

Tel: +61 2 9235 1666
'/>"/>

SOURCE Healthzone Limited
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Masimo Initiates Limited Release of First-Ever Noninvasive and Continuous Hemoglobin Monitors
2. EnrichMap Announces New Program To Reduce Medical Patient Noncompliance And Offers Healthcare Organizations A Limited Trial Test Opportunity
3. Solos Endoscopy, Inc. in Final Stages to Upgrade Pink Sheet Status from Limited to Current Information
4. Bunge Limited Schedules Third Quarter 2008 Earnings Release and Conference Call
5. Red Herring Awards ProGenTech Limited for the 2008 Red Herring Asia 100
6. Boston Scientific Acquires Labcoat Limited
7. Circ Pharma Limited Enters Into Development Agreement for Chrono Tramadol With Elan Corporation Plc
8. CSL Limited and Talecris Biotherapeutics Agree to Terminate Merger Agreement
9. Celtic Pharma Holdings Announces Investment in Novacta Biosystems Limited
10. Optimization and Scale-up of a Hydrodynamically Limited Anti-Solvent Crystallization Process: From Lab to Plant
11. Waytronx Announces Agreement for Development and Production of Its GASPT2 Device With UK-Based Ingenion Design Limited
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... Parallel ... clinical trials, announced today the Clinical Reach Virtual Patient Encounter CONSULT module ... circle with the physician and clinical trial team. , Using the CONSULT module, patients ...
(Date:6/27/2016)... June 27, 2016  Liquid Biotech ... funding of a Sponsored Research Agreement with The ... cells (CTCs) from cancer patients.  The funding will ... levels correlate with clinical outcomes in cancer patients ... will then be employed to support the design ...
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, ... second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical ... eBook by providing practical tips, tools, and strategies for clinical researchers. , “The ...
Breaking Biology Technology:
(Date:5/16/2016)... 2016   EyeLock LLC , a market leader ... of an IoT Center of Excellence in ... development of embedded iris biometric applications. EyeLock,s ... and security with unmatched biometric accuracy, making it the ... DNA. EyeLock,s platform uses video technology to deliver a ...
(Date:5/9/2016)... 9, 2016 Elevay is currently ... expanding freedom for high net worth professionals seeking travel ... globally connected world, there is still no substitute for ... duplicate sealing your deal with a firm handshake. This ... taking advantage of citizenship via investment programs like those ...
(Date:4/28/2016)... BANGALORE, India , April 28, 2016 ... of Infosys (NYSE: INFY ), and Samsung SDS, ... partnership that will provide end customers with a more ... payment services.      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) ... financial services, but it also plays a fundamental part in ...
Breaking Biology News(10 mins):